Related Experiment Video
Updated: Jun 11, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
A predicted S-type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through
Hua Ling1, Nazanin Saeidi, Bahareh Haji Rasouliha
1School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore 637459, Singapore.
Abstract:
The nucleic acid sequence at the positions 1067817-1066321 of Pseudomonas aeruginosa PAO1 genome was predicted to encode a novel S-type pyocin, designated S5, based on the genome sequence. However, its antimicrobial spectrum, activity and mechanism have not been investigated. Herein, we report that pyocin S5 has an antimicrobial activity against seven clinical P. aeruginosa isolates (DWW3, InA, InB, In3, In4, In7, and In8). Among them, DWW3 is most sensitive with a minimum inhibitory concentration of 12.6 microg/ml and a killing percentage of 95.7 at 225 microg/ml. Further, we demonstrated that the antimicrobial mechanism of pyocin S5 is membrane damage, evidenced by the leakage of intracellular materials, the increase of membrane permeability, and cell surface disruption.
Insights
A novel Pseudomonas aeruginosa pyocin, S5, demonstrates antimicrobial activity against clinical isolates by damaging cell membranes. This research investigates pyocin S5
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- The Pseudomonas aeruginosa genome sequence predicted a novel S-type pyocin, S5.
- The antimicrobial properties and mechanism of pyocin S5 remained uncharacterized.
Purpose of the Study:
- To investigate the antimicrobial activity, spectrum, and mechanism of the novel pyocin S5.
- To characterize pyocin S5 as a potential therapeutic agent against Pseudomonas aeruginosa.
Main Methods:
- Antimicrobial activity assays were performed against seven clinical Pseudomonas aeruginosa isolates.
- Minimum inhibitory concentration (MIC) and killing percentage were determined for pyocin S5.
- Mechanisms of action were assessed through analysis of intracellular material leakage, membrane permeability, and cell surface integrity.
Main Results:
- Pyocin S5 exhibited antimicrobial activity against all seven tested clinical Pseudomonas aeruginosa isolates.
- Isolate DWW3 showed the highest sensitivity to pyocin S5, with an MIC of 12.6 microg/ml.
- Pyocin S5 functions by causing membrane damage, leading to the leakage of intracellular components and disruption of cell surface.
Conclusions:
- Pyocin S5 possesses significant antimicrobial activity against clinical strains of Pseudomonas aeruginosa.
- The primary mechanism of pyocin S5 involves direct damage to the bacterial cell membrane.
- Pyocin S5 represents a promising candidate for novel antimicrobial strategies against Pseudomonas aeruginosa infections.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Gram-positive Cell Wall Synthesis

